Glaxo Wellcome Lotronex
Executive Summary
FDA's Gastrointestinal Drugs Advisory Committee will review alosetron for the treatment of irritable bowel syndrome in female patients with diarrhea predominance. The committee will meet Nov. 16 at the Holiday Inn in Gaithersburg, Md. beginning at 9 a.m